Dalton to manufacture new med; DKSH takes Tiger Balm to Myanmar;

> The investment arm of Swedish CMDO Recipharm will hold a 25% stake in Pharmanest, a pain drug developer, after making a 8 million Swedish krona investment in it. Release

> Dalton Pharma Services today announced the signing of a drug development and manufacturing contract with Ramsey Lake Pharmaceutical Corp. Release

And Finally... Market expansion specialist DKSH has been hired by Haw Par Healthcare to handle sales of its Tiger Balm pain reliever in Myanmar. Release

Suggested Articles

The cleaning procedures are so poor at a Zydus Cadila plant in India that the FDA says a sampling found 10 different cross-contaminated products.

Mylan is the most recent drugmaker facing the FDA's ire over a tainted API that led to a global recall of "sartan"-based drugs last year.

Merck MSD's $1.2 billion production restructuring has fallen on a site in France, where more than 200 manufacturing and R&D jobs will be swept away.